Showing 4961-4970 of 5910 results for "".
- Hoya Surgical Optics Announces Global Launch of CLEARlog Apphttps://modernod.com/news/hoya-surgical-optics-announces-global-launch-of-clearlog-app/2478409/During the virtual ESCRS, the CLEARlog app was launched with the support of Hoya Surgical Optics. CLEARlog, which stands for “Cataract & Lens Exchange Analysis & Register” log, is an app that allows Cataract and Refractive Lens Exchange (RLE) surgeons to quickly and eff
- Santen Joins Forces With Ophthalmologists in the Fight Against Antibiotic Resistancehttps://modernod.com/news/santen-joins-forces-with-ophthalmologists-in-the-fight-against-antibiotic-resistance/2478406/Santen announced the launch of the Re-SOLVE Antibiotic Resistance initiative, which aims to lead the way in the fight against antibiotic resistance in ophthalmology. The initiative will promote and encourage good antibiotic stewardship—a set of actions for the sustainable and effective use of ant
- Bausch Health Licenses Eyenovia’s Investigational Treatment For The Reduction Of Pediatric Myopia Progression In Children Ages 3-12https://modernod.com/news/bausch-health-licenses-eyenovias-investigational-treatment-for-the-reduction-of-pediatric-myopia-progression-in-children-ages-3-12/2478405/Bausch Health Companies and Eyenovia announced that an affiliate of Bausch Health has acquired an exclusive license in the United States and Canada for the development and commercialization of an investigational microdose formulati
- EyeCare4Kids Partners with 1-800 Contacts to Launch Sight the Worldhttps://modernod.com/news/eyecare4kids-partners-with-1-800-contacts-to-launch-sight-the-world/2478400/1-800 Contacts and nonprofit EyeCare4Kids announced the launch of Sight the World, which will utilize innovative vision care technology from 1-800 Contacts to provide free glasses and contact lenses for underserved adults and children globally. The announcement comes on World Sight Day, an intern
- Lilly, Incyte’s Olumiant Shows “Significant Effect” on COVID-19 Recovery Timeshttps://modernod.com/news/lilly-incytes-olumiant-shows-significant-effect-on-covid-19-recovery-times/2478401/Eli Lilly and Incyte shared more details, including mortality data, from the ongoing ACTT 2 trial evaluating their JAK1/JAK2 inhibitor Olumiant (baricitinib) in combination with Gilead Sciences’ Veklury (remdesivir) in patients with COVID-19 infection. The companies said last month that the
- AIVITA Biomedical’s Stem Cell Therapeutic in Vision Loss Published in Investigative Ophthalmology & Vision Sciencehttps://modernod.com/news/aivita-biomedicals-stem-cell-therapeutic-in-vision-loss-published-in-investigative-ophthalmology-vision-science/2478398/AIVITA Biomedical announced the publication of the peer-reviewed manuscript, “Retina organoid transplants develop photoreceptors and improve visual function in RCS rats with RPE dysfunction,” in the journal Investigative Ophthalmology & Visual Science. The
- Regeneron Asks FDA to Approve Emergency Use of REGN-COV2 for COVID-19https://modernod.com/news/regeneron-asks-fda-to-approve-emergency-use-of-regn-cov2-for-covid-19/2478394/Regeneron Pharmaceuticals said that it submitted a request to the FDA seeking emergency-use authorization for its REGN-COV2 investigational antibody combination for the treatment of COVID-19. REGN-COV2 is a combination of two monoclonal antibodies, REGN10933 and REGN10987, which has been designed
- Alcon Celebrates World Sight Day 2020 and Continues Commitment to Improving Worldwide Access to Eye Carehttps://modernod.com/news/alcon-celebrates-world-sight-day-2020-and-continues-commitment-to-improving-worldwide-access-to-eye-care/2478392/Alcon celebrates World Sight Day through its corporate giving and company-led initiatives focused on improving access to quality eye care. In the spirit of this year’s theme, “Hope in Sight,” Alcon associates will help spark donations to global nonprofit organizations that advance eye health. The
- GSK, Vir Biotechnology Move Anti-SARS-CoV-2 Monoclonal Antibody Into Phase 3https://modernod.com/news/gsk-vir-biotechnology-move-anti-sars-cov-2-monoclonal-antibody-into-phase-3/2478385/GlaxoSmithKline and partner Vir Biotechnology announced that the COMET-ICE study evaluating VIR-7831 as an early treatment for COVID-19 patients deemed to be at high risk of hospitalization will proceed into phase 3 testing, with preliminary results coming possibly before the end of this year. Th
- Allergan Announces REFRESH Concierge Program for ECPshttps://modernod.com/news/allergan-announces-refresh-concierge-program-for-ecps/2478382/Allergan announced the launch of its REFRESH Concierge service. The REFRESH Concierge is a full-service, dedicated remote support team providing eye care professionals with: Patient coupons Product education Help creating a REFRESH Direct eCommerce online sto